1. Home
  2. FERA vs NPCE Comparison

FERA vs NPCE Comparison

Compare FERA & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FERA
  • NPCE
  • Stock Information
  • Founded
  • FERA 2024
  • NPCE 1997
  • Country
  • FERA Cayman Islands
  • NPCE United States
  • Employees
  • FERA N/A
  • NPCE N/A
  • Industry
  • FERA
  • NPCE Medical Specialities
  • Sector
  • FERA
  • NPCE Health Care
  • Exchange
  • FERA Nasdaq
  • NPCE Nasdaq
  • Market Cap
  • FERA 317.4M
  • NPCE 292.9M
  • IPO Year
  • FERA 2025
  • NPCE 2021
  • Fundamental
  • Price
  • FERA $10.13
  • NPCE $9.15
  • Analyst Decision
  • FERA
  • NPCE Strong Buy
  • Analyst Count
  • FERA 0
  • NPCE 6
  • Target Price
  • FERA N/A
  • NPCE $16.67
  • AVG Volume (30 Days)
  • FERA 3.0
  • NPCE 205.3K
  • Earning Date
  • FERA 01-01-0001
  • NPCE 08-12-2025
  • Dividend Yield
  • FERA N/A
  • NPCE N/A
  • EPS Growth
  • FERA N/A
  • NPCE N/A
  • EPS
  • FERA N/A
  • NPCE N/A
  • Revenue
  • FERA N/A
  • NPCE $88,570,000.00
  • Revenue This Year
  • FERA N/A
  • NPCE $22.13
  • Revenue Next Year
  • FERA N/A
  • NPCE $6.07
  • P/E Ratio
  • FERA N/A
  • NPCE N/A
  • Revenue Growth
  • FERA N/A
  • NPCE 23.32
  • 52 Week Low
  • FERA $10.00
  • NPCE $5.45
  • 52 Week High
  • FERA $10.60
  • NPCE $18.98
  • Technical
  • Relative Strength Index (RSI)
  • FERA N/A
  • NPCE 51.74
  • Support Level
  • FERA N/A
  • NPCE $8.61
  • Resistance Level
  • FERA N/A
  • NPCE $8.99
  • Average True Range (ATR)
  • FERA 0.00
  • NPCE 0.53
  • MACD
  • FERA 0.00
  • NPCE 0.11
  • Stochastic Oscillator
  • FERA 0.00
  • NPCE 75.00

About FERA Fifth Era Acquisition Corp I Class A Ordinary Shares

Fifth Era Acquisition Corp I is a blank check company.

About NPCE Neuropace Inc.

NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.

Share on Social Networks: